PAD Clinical Trial
— EPROfficial title:
Effects of Heating on Exercise Pressor Reflex in Peripheral Artery Disease: Exercise Ability
The study objectives of this projects are to examine the hypothesis that the sympathetic and blood pressure responses to exercise will be attenuated during and after heat exposure in patients with peripheral artery disease, via altering the sensitivity of the muscle afferent receptors.
Status | Recruiting |
Enrollment | 32 |
Est. completion date | July 2025 |
Est. primary completion date | July 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years to 85 Years |
Eligibility | Inclusion Criteria: All subjects - Capable of giving informed consent - Any race or ethnicity - Men and women age 21- 85 years (inclusive) - Fluent in written and spoken English Patients with peripheral arterial disease (PAD) - Diagnosed with PAD (i.e., ankle-brachial index below 0.9) - Fontaine stage II or less - no pain while resting - Satisfactory history and physical exam Healthy subjects - Satisfactory history and physical examination - Free of acute medical conditions Exclusion Criteria: For patients with PAD and Healthy subjects - Age < 21 years - Pregnant or nursing women - Decisional impairment - Prisoners For patients with PAD - History of CAD with symptoms of unstable angina or myocardial infarction (<6 months) - History of epilepsy or seizure disorders For healthy subjects • Any other chronic diseases (heart, lung, neuromuscular disease or diabetes) |
Country | Name | City | State |
---|---|---|---|
United States | Penn State Milton S. Hershey Medical Center | Hershey | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Milton S. Hershey Medical Center |
United States,
Cui J, Blaha C, Moradkhan R, Gray KS, Sinoway LI. Muscle sympathetic nerve activity responses to dynamic passive muscle stretch in humans. J Physiol. 2006 Oct 15;576(Pt 2):625-34. doi: 10.1113/jphysiol.2006.116640. Epub 2006 Jul 27. — View Citation
Cui J, Blaha C, Sinoway LI. Whole body heat stress attenuates the pressure response to muscle metaboreceptor stimulation in humans. J Appl Physiol (1985). 2016 Nov 1;121(5):1178-1186. doi: 10.1152/japplphysiol.00212.2016. Epub 2016 Oct 7. — View Citation
Cui J, Boehmer J, Blaha C, Sinoway LI. Muscle sympathetic nerve activity response to heat stress is attenuated in chronic heart failure patients. Am J Physiol Regul Integr Comp Physiol. 2017 Jun 1;312(6):R873-R882. doi: 10.1152/ajpregu.00355.2016. Epub 2017 Mar 22. — View Citation
Cui J, Muller MD, Blaha C, Kunselman AR, Sinoway LI. Seasonal variation in muscle sympathetic nerve activity. Physiol Rep. 2015 Aug;3(8):e12492. doi: 10.14814/phy2.12492. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Walking time in minutes | Walking time on treadmill using Gardner protocol | Recording walking time to fatigue (up to 22 minutes maximum) during of every 3-4 hour study visit. | |
Primary | Blood pressure in mmHg | Cuffs placed on a finger and arm will monitor blood pressure. | Recorded continuously during the 3-4 hour study visit | |
Primary | Heart Rate in beats per minute | Electrocardiogram (ECG) patches attached to a Cardiocap will monitor heart rat | Recorded continuously during the 3-4 hour study visit | |
Secondary | Internal Temperature in degrees C | The internal temperature (Tcore) will be measured from the stomach/intestines via a telemetry pill swallowed by subjects. | Recorded continuously during the 3-4 hour study visit | |
Secondary | Near infrared spectroscopy (NIRS) in arbitrary units | This system is designed specifically for non-invasive measurements of muscle tissue. The system measures the tissue saturation of the investigated muscle, called the 'tissue saturation index' (TSI). | Recorded continuously during the 3-4 hour study visit |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03157531 -
Safety and Effectiveness of B-Laser™ in Subjects Affected With Infrainguinal PAD
|
N/A | |
Recruiting |
NCT03668353 -
Recombinant SeV-hFGF2/dF Injection for PAOD
|
Phase 1 | |
Not yet recruiting |
NCT04108806 -
Study of Peripheral Arterial Calcification
|
N/A | |
Completed |
NCT02561299 -
Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study
|
N/A | |
Completed |
NCT01355406 -
Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System
|
N/A | |
Recruiting |
NCT06239493 -
IVUS-Guided Treatment for Percutaneous Vascular Interventions
|
||
Active, not recruiting |
NCT00390767 -
Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease (PAD)
|
Phase 1/Phase 2 | |
Completed |
NCT02907203 -
Clinical Investigation of the GORE® Drug-Coated PTA Balloon Catheter (GORE® DCB Catheter)
|
||
Recruiting |
NCT03683628 -
Treatment of Intermittent Claudication by G-CSF-mobilized PB-MNC
|
N/A | |
Recruiting |
NCT03686228 -
Treatment of No-option CLI by G-CSF-mobilized PB-MNC
|
N/A | |
Active, not recruiting |
NCT04204564 -
VISION and VQI Paclitaxel Safety Analysis
|
||
Terminated |
NCT01341340 -
The ABSORB BTK (Below The Knee) Clinical Investigation
|
N/A | |
Completed |
NCT03135535 -
Micro-mobile Foot Compression and Diabetic Foot
|
Phase 2 | |
Completed |
NCT03452293 -
SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients
|
||
Recruiting |
NCT05361967 -
Tack Optimized Balloon Angioplasty Post-Market Study
|
||
Active, not recruiting |
NCT02500303 -
Influence of Diabetes on Lower Limb Amputation
|
N/A | |
Completed |
NCT03358355 -
Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial
|
Phase 1/Phase 2 | |
Withdrawn |
NCT03516383 -
Pulse Wave Velocity Imaging in the Assessment of PAD
|
||
Completed |
NCT03590769 -
Arterial Imaging of Inflammation and Resolution After Endovascular Surgery
|
Phase 1 | |
Completed |
NCT01938391 -
Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal
|
N/A |